Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
170M
-
Number of holders
-
211
-
Total 13F shares, excl. options
-
69.6M
-
Shares change
-
+939K
-
Total reported value, excl. options
-
$2.25B
-
Value change
-
-$5.73M
-
Put/Call ratio
-
0.45
-
Number of buys
-
107
-
Number of sells
-
-124
-
Price
-
$32.31
Significant Holders of Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT) as of Q1 2024
290 filings reported holding IMVT - Immunovant, Inc. - Common Stock, par value $0.0001 per share as of Q1 2024.
Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT) has 211 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 69.6M shares
of 170M outstanding shares and own 41% of the company stock.
Largest 10 shareholders include FMR LLC (7.66M shares), VANGUARD GROUP INC (6.48M shares), BlackRock Inc. (4.48M shares), STATE STREET CORP (3.64M shares), PERCEPTIVE ADVISORS LLC (2.96M shares), ARMISTICE CAPITAL, LLC (2.16M shares), Alpine Global Management, LLC (1.88M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.86M shares), VIKING GLOBAL INVESTORS LP (1.81M shares), and Logos Global Management LP (1.78M shares).
This table shows the top 211 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.